OpenLegislation

Regulation 4 Amendment of the Controlled Drugs (Drug Precursors) (Intra-Community Trade and Community External Trade) Regulations 2010

Original text. Later amendments are not shown.

(1)

The Controlled Drugs (Drug Precursors) (Intra-Community Trade and Community External Trade) Regulations 2010f1 are amended as follows.

(2)

In regulation 1 (citation, commencement, and interpretation) in paragraph 2—

(a)

for sub-paragraph (c) substitute—

“(c)

the “2004 Community Regulation” means—

(i)

in respect of Northern Ireland, Regulation (EC) No. 273/2004 of the European Parliament and of the Council dated 11th February 2004f2 as it has effect in EU law, or;

(ii)

in respect of Great Britain, Regulation (EC) No. 273/2004 of the European Parliament and of the Council dated 11th February 2004;”

(b)

for sub-paragraph (d) substitute—

“(d)

the “2005 Community Regulation” means—

(i)

in respect of Northern Ireland, Council Regulation (EC) No. 111/2005 dated 22nd December 2004f3 as it has effect in EU law, or;

(ii)

in respect of Great Britain, Council Regulation (EC) No. 111/2005 dated 22nd December 2004; and”.

(3)

In regulation 2 (prescribed fee)—

(a)

in paragraph (7) after “regulation 6(1)” insert “or 6(1A)”;

(b)

in paragraph (8) after “regulation 7(1)” insert “or 7(2A)(a)”;

(c)

after paragraph (8) insert—

“(8A)

No fee is payable under paragraphs (7) and (8) in respect of export authorisations or import authorisations that are issued in relation to the movement of scheduled substances between Northern Ireland and Great Britain.”.

Annotations

Footnotes

f1

S.I. 2010/2564.

f2

OJ No. L 47, 18.02.2004, p.1, as last amended by Commission Delegated Regulation (EU) 2025/1475 (OJ No. L, 2025/1475, 25.7.2025).

f3

OJ No. L 22, 26.1.2005, p.1, as last amended by Commission Delegated Regulation (EU) 2025/1475 (OJ No. L, 2025/1475, 25.7.2025).